Impact Of Physiotherapy And Botox In Improving Functional Outcomes Among Post Stroke Focal Dyston… (NCT03664375) | Clinical Trial Compass
CompletedNot Applicable
Impact Of Physiotherapy And Botox In Improving Functional Outcomes Among Post Stroke Focal Dystonia Patients
39 participantsStarted 2015-11
Plain-language summary
This study was conducted to assess the combine role of Physiotherapy by providing task specific trainings and Botulinum Toxin Type A in improving the functional outcomes of upper limb in post stroke patients with focal hand dystonia.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients having first episode of unilateral stroke
* At least 6 months of post stroke duration presenting with post stroke focal dystonia of the upper limb.
* No previous exposure of the affected hand of Botox.
* Reduced upper limb functions
* Both genders will be included equally.
Exclusion Criteria:
* Significant speech or cognitive impairment which impedes the ability to perform the assessment.
* Other significant upper limb impairment e.g. fracture or frozen shoulder within 6 months.
* Severe arthritis, amputation, evidence of fixed contracture, pregnancy or lactating womens.
* Other diagnosis likely to interfere with rehabilitation or outcome assessments, e.g. blind, malignancy,
* Other conditions which may contribute to upper limb spasticity, e.g. multiple sclerosis, cerebral palsy.
* Use of botulinum toxin to the upper limb in the previous 4 months.
* Contraindications to intramuscular injection.
* Contraindications /allergy to botulinum toxin type A, which include bleeding disorders, myasthenia gravis and concurrent use of aminoglycosides.